Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07022990 · ClinicalTrials.gov registry record · NA
Improving Medication Management in World Trade Center Responders
A NA study of Polypharmacy, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07022990: Recruiting NA study of Polypharmacy, sponsored by Icahn School of Medicine at Mount Sinai.
NCT07022990 is a NA study of Polypharmacy that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 50 participants, below the 1,526-participant average among 11 other Polypharmacy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07022990, a NA study of Polypharmacy, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
By 2030, the majority of World Trade Center (WTC) rescue and recovery workers (responders) will be aged 65 and over and at risk for aging-related conditions and consequences including the concurrent use of five or more medications (i.e., polypharmacy). The purpose of this research study is to investigate an educational approach targeting polypharmacy through de-prescribing unnecessary and burdensome medications via the support of informed discussions between WTC responders and their prescribing physicians.
Primary Outcome
Brief Medication Questionnaire 2 (BMQ2) to measure participants feel/views about Z Drugs, Skeletal Muscle Relaxants, Proton Pump Inhibitors and Benzodiazepines. Min scale: Strongly Agree - Max scale: Strongly Disagree. Higher score means patient strongly disagrees with the extent medications makes them feel/views about their medication.
Conditions Studied
Interventions
- OTHER Educational brochure for deprescribing
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-04-08 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT07022990 shows while recruiting
NCT07022990 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,526-participant average among 11 other Polypharmacy trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Polypharmacy appearing as the primary indexed condition, and to 1 intervention - of which Educational brochure for deprescribing is the first listed.
NCT07022990 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07022990 about?
NCT07022990 is a clinical study titled "Improving Medication Management in World Trade Center Responders". By 2030, the majority of World Trade Center (WTC) rescue and recovery workers (responders) will be aged 65 and over and at risk for aging-related conditions and consequences including the concurrent use of five or more medications (i.e., polypharmacy). The purpose of this research study is to invest...
What is the current status of trial NCT07022990?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-04-08. Estimated completion is 2026-06-30.
What conditions does trial NCT07022990 study?
This clinical trial studies the following conditions: Polypharmacy.
What interventions are being tested in trial NCT07022990?
The interventions under investigation include: Educational brochure for deprescribing (OTHER).
Who is sponsoring clinical trial NCT07022990?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07022990 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polypharmacy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07022990's enrollment target sits among peer trials
50 9th of 11 higher than 3 of 11 other Polypharmacy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Polypharmacy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Geriatric Emergency Department Pharmacologic Harm Prevention Project
RECRUITING · NA
-
Effectiveness of PGx Testing
ACTIVE NOT RECRUITING · NA
-
Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges R01 Trial
ACTIVE NOT RECRUITING · NA
-
Preemptive Pharmacogenomics Testing Among Geriatric Patients
ACTIVE NOT RECRUITING · NA
-
Pharmacist Intervention to Reduce Post-Hospitalization Utilization
ACTIVE NOT RECRUITING · NA
-
A Randomized Controlled Trial to Deprescribe for Older Patients With Polypharmacy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI